CABA

Cabaletta Bio Stock Analysis

AI Rating

Fair
  • Quality3/10
  • Growth↓ 1/10
  • Value↓ 4/10
Cabaletta Bio sales and earnings growth
CABA Growth
Low
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -17.13%
  • FCF Y/Y↓ -43.91%
Cabaletta Bio gross and profit margin trends
CABA Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -265.42%
Cabaletta Bio net debt vs free cash flow
CABA Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -71.1

Cabaletta Bio stock volatility is higher than the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗